C

Conformis

Biotech & Life Sciences · Billerica, United States · Founded 2004 · IPO 2015

Conformis, Inc. operates as a medical technology company, positioning itself at the intersection of advanced imaging and additive manufacturing to address the orthopedic joint replacement market. Founded in 2004 by Dr. Philipp Lang, a radiologist and professor with an M.D. and MBA, the company was born from his dissatisfaction with the limitations of standard, off-the-shelf implants. Lang's background in musculoskeletal radiology at institutions like Harvard Medical School and his experience in the medical device industry directly informed the company's core concept of making the implant fit the patient, not the other way around. The company's business model centers on its proprietary iFit Image-to-Implant technology platform, which utilizes CT scans to create a 3D digital model of a patient's unique anatomy. This data-driven approach allows for the design and manufacture of individually sized and shaped joint replacement implants for knees and hips, along with patient-specific surgical instrumentation. This process aims to provide a more precise anatomical fit, preserve healthy bone, and simplify the surgical procedure for orthopedic surgeons. Revenue is generated through the sale of these personalized implant systems directly to hospitals and other healthcare facilities. The company serves a global market, with a sales presence in the United States, Europe, and Asia. Conformis' product line includes a range of knee and hip replacement systems designed to treat conditions like osteoarthritis. Key offerings have included the iTotal CR (cruciate-retaining) and iTotal PS (posterior-stabilized) for total knee replacements, as well as partial knee solutions like the iUni and iDuo. The company also developed the Conformis Hip System. A significant milestone was the company's initial public offering (IPO) on July 7, 2015, trading on the NASDAQ under the symbol CFMS. Over its history, Conformis has secured numerous FDA 510(k) clearances for its products, starting with its iTotal system in 2011 and its hip system in 2017. Despite its technological advancements and having sold over 149,000 implants, the company faced financial struggles. In September 2023, Conformis was acquired by restor3d, a private medical device company specializing in 3D-printed orthopedic solutions. The acquisition combined restor3d's expertise with Conformis's established product lines and intellectual property, with the goal of creating a comprehensive personalized orthopedic device company. Keywords: patient-specific implants, custom joint replacement, orthopedic medical device, 3D printed implants, knee arthroplasty, hip arthroplasty, personalized surgery, medical imaging technology, iFit technology, surgical instrumentation, osteoarthritis treatment, additive manufacturing, medical device manufacturing, orthopedic surgery solutions, patient-conforming implants, knee replacement systems, hip replacement systems, restor3d, Philipp Lang, custom medical devices